Error processing SSI file
Error processing SSI file
Weekly Report: Influenza Summary Update
Week ending February 28, 2004-Week 8
Error processing SSI fileThe following information may be quoted:
Synopsis:
Influenza activity remained low during the week of February 22-28, 2004. The percentage of patient visits for influenza-like illness (ILI) remained below the national baseline (2.5%). During week 8, mortality due to pneumonia and influenza (P&I) remained below the epidemic threshold (8.3%). Eight (1.2%) of 643 specimens collected from throughout the United States and tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories were positive for influenza. There were no reports of widespread or regional influenza activity from state and territorial epidemiologists during week 8. Five states reported local activity, 32 states, New York City, the District of Columbia, Guam, and Puerto Rico reported sporadic activity, and 12 states reported no influenza activity.
Laboratory Surveillance*:
During week 8, WHO and NREVSS laboratories reported 643 specimens tested for influenza viruses, and 8 (1.2%) were positive. Of these, 3 were influenza A (H3N2) viruses, 3 were influenza A viruses that were not subtyped, and 2 were influenza B viruses.
Since September 28, WHO and NREVSS laboratories have tested 104,961 specimens for influenza viruses, of which 23,540 (22.4%) were positive. Of these, 23,383 (99.3%) were influenza A viruses, and 157 (0.7%) were influenza B viruses. Of the 23,383 influenza A viruses, 6,407 (27.4%) have been subtyped; 6,405 (99.9%) were influenza A (H3N2) viruses and 2 (0.1%) were influenza A (H1) viruses.
Antigenic Characterization:
CDC has antigenically characterized 668 influenza viruses collected by U.S. laboratories since October 1: two influenza A (H1) viruses, 648 influenza A (H3N2) viruses, and 18 influenza B viruses. The hemagglutinin proteins of the influenza A (H1) viruses were similar antigenically to the hemagglutinin of the vaccine strain A/New Caledonia/20/99. Of the 648 influenza A (H3N2) isolates that have been characterized, 106 (16.4%) were similar antigenically to the vaccine strain A/Panama/2007/99 (H3N2), and 542 (83.6%) were similar to the drift variant, A/Fujian/411/2002 (H3N2). Sixteen influenza B viruses characterized were similar antigenically to B/Sichuan/379/99 and 2 were similar antigenically to B/Hong Kong/330/2001.
Pneumonia and Influenza (P&I) Mortality Surveillance:
During week 8, 7.7% of all deaths reported by the vital statistics offices of 122 U.S. cities were due to pneumonia and influenza. This percentage is below the epidemic threshold of 8.3% for week 8.
Influenza-like Illness Surveillance *:
The percentage of patient visits to approximately 1,000 U.S. sentinel providers nationwide for ILI was 1.1%** during week 8, which is below the national baseline of 2.5%. The percentage of patient visits for ILI in each of the nine surveillance regions*** was below 2.0%. Due to wide variability in regional level data, it is not appropriate to apply the national baseline to regional level data.
View
Chart Data
| View Full Screen
Influenza Activity as Assessed by State and Territorial Epidemiologists**:
There were no reports of widespread or regional activity for week 8. Local activity was reported in 5 states (Florida, Idaho, Maryland, New Jersey, and West Virginia). Sporadic activity was reported in 32 states (Alaska, Arizona, California, Colorado, Connecticut, Georgia, Hawaii, Kansas, Kentucky, Louisiana, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Mexico, New York, North Carolina, North Dakota, Ohio, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Wisconsin, and Wyoming), New York City, the District of Columbia, Guam, and Puerto Rico. Twelve states reported no influenza activity (Alabama, Arkansas, Delaware, Illinois, Iowa, New Hampshire, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, and South Dakota). Indiana did not report.
--------------------------------------------------------------------------------
* Reporting is incomplete for this week. Numbers may change as more reports are received.
** The national and regional percentage of patient visits for ILI is weighted on the basis of state population.
*** Surveillance Regions: New England (Connecticut, Maine, Massachusetts, New Hampshire, Vermont, Rhode Island); Mid-Atlantic (New Jersey, New York City, Pennsylvania, Upstate New York); East North Central (Illinois, Indiana, Michigan, Ohio, Wisconsin); West North Central (Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, South Dakota); South Atlantic (Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, Washington, D.C., West Virginia); East South Central (Alabama, Kentucky, Mississippi, Tennessee); West South Central (Arkansas, Louisiana, Oklahoma, Texas); Mountain (Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Utah, Wyoming); Pacific (Alaska, California, Hawaii, Oregon, Washington)
Report prepared March 4, 2004
Error processing SSI file